Skip to content
PICO Portalanswers from OpenAlex

The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response

PaperCitations, authors & open-access status

The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response is a paper indexed in PICO Portal from OpenAlex.

How many citations does The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response have?

PICO Portalcitation count

The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response has 48 citations in the OpenAlex counts PICO Portal stores.

When was The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response published?

PICO Portalyear

The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response has 2020 year in the PICO Portal index.

What is the open-access status of The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response?

PICO Portaloa status

The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response has gold oa status in the PICO Portal index.

What is the DOI of The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response?

PICO Portaldoi

The DOI for The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response is on the source record.

What is the PMID of The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response?

PICO Portalpmid

The PMID for The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response is on the source record.

What is the OpenAlex record for The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response?

PICO Portalopenalex

The OpenAlex for The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial